Schedule 13G ownership disclosure

AN2 Therapeutics, Inc.

Common Stock and Warrants · CUSIP: 037326105

Event date: 2025-12-31

Filing-level shares
2,975,164.00
Percent of class
5.4%
  • Almitas Capital LLC

    Shares: 2,975,164.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001596468-26-000004
Form type
SCHEDULE 13G
Filer
AN2 Therapeutics, Inc.
CIK
CIK 1880438
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub